EMPIRE CONSULTING GROUP

Lobbying for GILEAD SCIENCES INC. · Biopharmaceutical Company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $50,000.00 income · posted Jul 16, 2026

Lobbying activity 1

Health Issues

Issues related to triple negative breast cancer treatment. Issues related to health access.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.